Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: ALS and Airway Clearance (ALSAC) Therapy [NA]

View source ↗

Summary

Completed clinical trial investigating ALS and airway clearance therapy (ALSAC) for amyotrophic lateral sclerosis with respiratory muscle weakness; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALSAC Therapy (ALSAC Therapy)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Amyotrophic Lateral Sclerosis, Respiratory Muscle Weakness | NA | Status: COMPLETED | Results posted: 2021-11-04